Vimarsana
Biggest News Aggregation in the World

Diego Ardig News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Diego Ardig. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Diego Ardig Today - Breaking & Trending Today

Oak Hill Bio and Chiesi Group Announce First Patient Enrolled in the Resumed Phase 2b Clinical Study Evaluating OHB-607 for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease in Premature Infants - Vimarsana News

Oak Hill Bio and Chiesi Group Announce First Patient Enrolled in the Resumed Phase 2b Clinical Study Evaluating OHB-607 for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease in Premature Infants

Design of the multi-center study is based on Phase 2a clinical data, which showed a decrease in the occurrence of severe bronchopulmonary dysplasia (BPD), a condition for which there are

Enzyme replacement therapy approved for Fabry disease - Vimarsana News

Enzyme replacement therapy approved for Fabry disease

The European Commission (EC) has given approval to the first PEGylated enzyme replacement therapy to treat Fabry disease.

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Authorization of PRX-102 (pegunigalsidase alfa) for the Treatment of Fabry Disease - Vimarsana News

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Authorization of PRX-102 (pegunigalsidase alfa) for the Treatment of Fabry Disease

/PRNewswire/ -- Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected...